Literature DB >> 12906308

Osteoblasts cultured from osteoporotic bone: a comparative investigation on human and animal-derived cells.

Paola Torricelli1, Milena Fini, Gianluca Giavaresi, Roberto Giardino.   

Abstract

In vitro studies on pathophysiology and innovative treatments of many orthopaedic diseases, based on the investigations of cells from pathologic skeletal tissues, greatly improve basic knowledge of osteoporosis. Primary osteoblast (OB) cultures derived from osteopenic bone from different species (human, rat, sheep) were compared to assess the differences that should be taken into account when performing in vitro biocompatibiliy tests or investigating pharmacological and physical treatments. Primary OB were isolated from osteopenic patients and animals by well-established methods and their metabolism was assessed with or without 1,25(OH)2D3. The greatest significant differences were observed between rat and human cells both under basal conditions and after 1,25(OH)2D3 stimulation. In addition, the response to 1,25(OH)2D3 stimulation of OBs from osteopenic rats was significantly different from that of human and sheep OB cultures, in terms of NO, OC, IL-6, and TGF-beta1. Cells derived from osteopenic sheep behaved much more similarly to those from humans, except for a significant difference in terms of TGF-beta1 observed both under basal conditions and after stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906308     DOI: 10.1081/bio-120023157

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  3 in total

1.  Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures.

Authors:  C Méndez-Dávila; C García-Moreno; C Turbì; C de la Piedra
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Osteopenic bone cell response to strontium-substituted hydroxyapatite.

Authors:  E Boanini; P Torricelli; M Fini; A Bigi
Journal:  J Mater Sci Mater Med       Date:  2011-06-21       Impact factor: 3.896

Review 3.  Animal models for fracture treatment in osteoporosis.

Authors:  Marcus Egermann; J Goldhahn; E Schneider
Journal:  Osteoporos Int       Date:  2005-03-05       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.